Public batch ID: BPC157-B002 Current batch Batch B002 Janoshik Analytical batch-specific analytical report Proves identity Proves purity Checks amount Sterility not tested unless listed Prior batches Batch B001 March 2026 - Janoshik verified Research & library Research review Scientific background, literature, and compound context COA library Browse current and supporting batch documentation Scope limit: COAs document analytical testing for research materials
Customer Service If there's anything that is not mentioned in this operating instructions, please contact us in time for consultation
No additional indications have been approved beyond HIV-associated lipodystrophy, though ongoing research continues into NAFLD, cognitive function, and other metabolic applications
If someone exhibits symptoms of alcohol poisoningconfusion, vomiting, seizures, slow or irregular breathingimmediate medical attention is critical
April 4, 2025
Semaglutides and tirzepatides are medications originally developed to treat type 2 diabetes but are now widely used for weight loss due to their effects on appetite control and metabolism
